Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High ApoC-III levels were shown to increase total triglyceride levels by an accumulation of VLDL and chylomicrons [166–169]”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [167]
In the citing paper
“These data are consistent with previous studies showing that transgenic mice with overexpression of human apolipoprotein C3 had hypertriglyceridemia due to decreased lipoprotein lipase activity,16”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [16]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
Virgil Brown, W., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 491
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citation
Research works printed but not linked: 2
- COLE, T.G., BIOCOMMUNIQUE 4: 4 (1988).
- PROTTER, A. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 3: 449 (1984).
Cited by
Items 401–500 of 543
Fiévet, C., Fruchart, J.-C., & Staels, B. (2007) · Frontiers in bioscience · doi:10.2741/2376 · Cited by 13
Howell, M. L., Li, R., Zhang, R., Li, Y., Chen, W., & Chen, G. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1889-y · Cited by 10
Kobayashi, J., Murano, S., Yokote, K., Mori, S., Matsunaga, A., Sasaki, J., Takahashi, K., Bujo, H., & Saitō, Y. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00219-3 · Cited by 10
Apolipoprotein‐B subclasses as acceptors of cholesteryl esters transferred by CETP
Lee, D. M., Alaupovic, P., Knight‐Gibson, C., & Bagdade, J. D. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02001.x · Cited by 10
Chen, X., Tian, H., & Liu, R. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.02.020 · Cited by 10
Apolipoprotein genes and atherosclerosis
Breslow, J. L. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00235516 · Cited by 16
Self-citationGenetic predisposition to coronary heart disease and gene for apolipoprotein-CIII
Taş, S. (1991) · The Lancet · doi:10.1016/0140-6736(91)90770-p · Cited by 9
Thu, N. N., Mai, T. T. T., Ohmori, R., Kuroki, M., Chuyên, N. V., Hung, N. T. K., Kawakami, M., & Kondo, K. N. (2006) · Journal of Nutrition · doi:10.1093/jn/136.6.1488 · Cited by 9
Parzianello, L., Oliveira, G., & Coelho, J. C. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008005000022 · Cited by 9
Ehx, G., Gérin, S., Mathy, G., Franck, F., Oliveira, H. C. F., Vercesi, A. E., & Sluse, F. E. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-116 · Cited by 9
Dancer, M. S., Caussy, C., Filippo, M. D., Moulin, P., Marçais, C., & Charrière, S. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.024 · Cited by 10
Zhang, W., Liu, L., Zhou, M., Su, S., Dong, L., Meng, X., Li, X., & Wang, C. (2022) · Animals · doi:10.3390/ani13010013 · Cited by 10
Yamamoto, M., Oohashi, T., Katoh, N., & Oikawa, S. (2000) · Journal of Veterinary Medical Science · doi:10.1292/jvms.62.1033 · Cited by 9
Hypercholesterolemia induces differential expression of rabbit apolipoprotein A and C genes
Crespo, P., Ordovás, J. M., Albajar, M., Rodríguez-Rey, J. C., Ortiz, J. M. B., & León, J. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90180-o · Cited by 9
Cholesteryl ester transfer protein's role in high-density lipoprotein metabolism
Melchior, G. W., & Marotti, K. R. (1995) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00002-q · Cited by 10
Effect of hepatic insulin expression on lipid metabolism in diabetic mice
Qu, S., Zhang, T., & Dong, H. H. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12293 · Cited by 9
Uncovering the role of apolipoprotein C-III in insulin resistance
Aguilar-Recarte, D., Palomer, X., & Vázquez‐Carrera, M. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.09.003 · Cited by 9
Yang, Y., Zheng, Z., Chen, Y., Wang, X., Wang, H., Si, Z., Meng, R., & Wu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-29491-2 · Cited by 10
Sviridov, D. O., Dasseux, A., Reimund, M., Pryor, M., Drake, S. K., Jarin, Z., Wolska, A. T., Pastor, R. W., & Remaley, A. T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1223920 · Cited by 9
Apolipoprotein Gene Polymorphisms as Cause of Cholesterol QTLs in Mice
Jun-ichi, S. U. T. O. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.583 · Cited by 8
Li, Y., Ruixing, Y., Li, M., Kela, L., Xingjiang, L., Lin, Z., Wanying, L., Shangling, P., Dezhai, Y., & Weixiong, L. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181e5e146 · Cited by 8
Adenovirus-Mediated Gene Transfer as an In Vivo Probe of Lipoprotein Metabolism
Leiden, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.9.2046 · Cited by 8
Nucleotide sequences of the Macaca fascicularis apolipoprotein C-III and A-IV genes
Osada, J., Pocovı́, M., Nicolosi, R. J., Schaefer, E. J., & Ordovás, J. M. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90226-4 · Cited by 8
Dedousis, N. L., Teng, L., Kanshana, J. S., & Kohan, A. B. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100284 · Cited by 7
Chen, B.-F., Chien, Y., Tsai, P.-H., Perng, P.-C., Yang, Y., Hsueh, K., Liu, C.-H., & Wang, Y. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000564 · Cited by 7
Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
Ginsberg, H. N., & Reyes‐Soffer, G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131333 · Cited by 7
Transcriptional Control of Gene Expression in Hepatic Cells
Ciliberto, G., Colantuoni, V., Francesco, R. D., Simone, V. D., Monaci, P., Nicosia, A., Ramji, D. P., Toniatti, C., & Cortese, R. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6811-3_7 · Cited by 8
Yamamoto, M., & Katoh, N. (2000) · Journal of Veterinary Medical Science · doi:10.1292/jvms.62.49 · Cited by 7
Mouse models as tools for dissecting disorders of lipoprotein metabolism
Marschang, P., & Herz, J. (2003) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084-9521(02)00169-6 · Cited by 8
Apolipoprotein C-III SstI Genotypes Modulate Exercise-Induced Hypotriglyceridemia
Woo, S.-K., & Kang, H. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000128200.38372.82 · Cited by 7
Yu, J., Wang, H., Yang, S.-M., Yuan, J., Chen, L., Chen, C. L., Huang, D. F., Wang, Y., Ju, S.-Q., & ZHU, J.-Y. (2009) · Laboratory Medicine · doi:10.1309/lmubypdivgqwoy2u · Cited by 7
Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome
Benes, L. B., Brandt, E. J., & Davidson, M. H. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1419863 · Cited by 6
Silencing ApoC3 alleviates LPS-induced acute lung injury by inhibiting TLR signaling pathway
Qi, Y., Chen, C., Li, X., Liu, Y., Qi, H., Xue, Y., & Yang, F. (2023) · Immunologic Research · doi:10.1007/s12026-023-09379-z · Cited by 6
Kim, D. H., Lee, S., Noh, S. G., Lee, J., & Chung, H. Y. (2024) · Aging · doi:10.18632/aging.205610 · Cited by 9
Bandegi, A. R., Firoozrai, M., Eidgahi, M. R. A., & Kokhaei, P. (2011) · PubMed Central · Cited by 6
Conde‐Knape, K., Okada, K., Ramakrishnan, R., & Shachter, N. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400185-jlr200 · Cited by 7
Srivastava, R. A. K., He, S., & Newton, R. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.004 · Cited by 6
Genetically Engineered Large Animals in Biomedicine
Wolf, E., Kind, A., Aigner, B., & Schnieke, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-92348-2_9 · Cited by 6
Katoh, N. (2001) · Journal of Veterinary Medical Science · doi:10.1292/jvms.63.95 · Cited by 6
Bard, J., Ose, L., Hagen, E., Duriez, P., Pfister, P., Fruchart, J., Dallongeville, J., & EUROPEANFLUVASTATINSTUDYGROUP (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80021-9 · Cited by 6
The genetic basis of lipoprotein disorders Introduction and overview
Breslow, J. L. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01251.x · Cited by 6
Self-citationIssues in interpretation of toxicological data for use in risk assessment
Furst, A. (1994) · Journal of Hazardous Materials · doi:10.1016/0304-3894(94)00051-4 · Cited by 5
Mécanismes des hyperlipidémies dues aux immunosuppresseurs
Guéguen, Y., Ferrari, L., & Batt, A. (2004) · Therapies · doi:10.2515/therapie:2004078 · Cited by 6
Yue, Y., Jiang, H., Yan, S., Fu, Y., Liu, C., Sun, X.-L., Chai, M., Gao, Y., Yuan, B., Chen, C., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1373222 · Cited by 5
Triglyceride-Rich Lipoproteins
Le, N., & Brown, W. V. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_4 · Cited by 5
Zannis, V. I., Liu, T., Zanni, M. V., Kan, H.-Y., & Kardassis, D. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.064 · Cited by 5
Polymorphism in Apoprotein-CIII Gene and Coronary Heart Disease
Hussain, S. S., Buraiki, J. A., Dzimiri, N., Butt, A. I., Vencer, L., Basco, C., & Khan, B. A. (1999) · Annals of Saudi Medicine · doi:10.5144/0256-4947.1999.201 · Cited by 5
Jimenes, D. R., Teixeira, N. R., Pereira, A. V., Berti, J. A., Barbosa, C. P., & Sant’Ana, D. D. M. G. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111261 · Cited by 4
Uncovering the role of apolipoprotein C-III in insulin resistance
Aguilar-Recarte, D., Palomer, X., & Vázquez‐Carrera, M. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.04.002 · Cited by 9
den Hollander, B., Brands, M. M. M. G., Nijhuis, I. J. M., van Troostwijk, L. J. A. E. D., van Essen, P., Hofsteenge, G. H., Koot, B. G. P., Müller, A. R., Tseng, L. A., Stroes, E. S. G., et al. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108347 · Cited by 4
Decreases in Serum Apolipoprotein C-III Concentration in Cows with Ethionine-Induced Fatty Liver
Nitanai, A., Katoh, N., Oikawa, S., SAITOH, M., HAMADA, M., KUTSUZAWA, A., Tharwat, M., Uchida, E., Endoh, D., Kurosawa, T., et al. (2004) · Journal of Veterinary Medical Science · doi:10.1292/jvms.66.1113 · Cited by 4
Lipoproteins: A Source of Cardiac Lipids
Drosatos, K., & Goldberg, I. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_2 · Cited by 4
O’Brien, R. M., & Granner, D. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118317 · Cited by 4
Wijnholds, J., Philipsen, S., Pruzina, S., Fraser, P., Grosveld, F. G., & Geert, A. B. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.7.1629 · Cited by 4
Farstad-O’Halloran, K., Sooda, A., Iqbal, T., Wilton, S. D., & Aung-Htut, M. T. (2025) · Genes · doi:10.3390/genes16040412 · Cited by 3
Wassef, H., Davignon, J., Prud’homme, D., RABASA-LHORET, R. P. R., & Faraj, M. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.06.004 · Cited by 6
Kinetic analysis of apolipoproteins in postprandial hypertriglyceridaemia rabbits
Hata, M., Ito, T., & Ohwada, K. (2009) · Laboratory Animals · doi:10.1258/la.2008.007004 · Cited by 3
Han, Y., Qi, R., & Liu, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.147 · Cited by 3
The forkhead box O family in insulin action and lipid metabolism
Lee, S., Zhu, C., Yamauchi, J., Zhu, P., Feng, X., Qu, S., & Dong, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00013-0 · Cited by 4
Júnior, N. R. T., Jimenes, D. R., Schultz, C., Almeida, D. L., Mathias, P. C. D. F., & Berti, J. A. (2024) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2024e13202 · Cited by 5
Apolipoprotein C-III can specifically bind to hepatic plasma membranes
Fang, D. Z., & Liu, B. W. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007038129481 · Cited by 4
Transgenic Animals in Lipoprotein Research
Aalto‐Setälä, K. (1992) · Annals of Medicine · doi:10.3109/07853899209147846 · Cited by 3
Yin, Y., & Olivecrona, G. (1999) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(99)00097-8 · Cited by 3
A novel type hypertriglyceridemia observed in FLS mice
Takahashi, M., Saibara, T., Nemoto, Y., Ono, M., Akisawa, N., Iwasaki, S., Toda, K., Ogawa, Y., Wakatsuki, A., Inagaki, S., et al. (2003) · Lipids · doi:10.1007/s11745-003-1116-7 · Cited by 3
Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum
Wang, Y., Song, Z., Wagner, J. D., Pachuk, C. J., & Subramanian, R. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d011148 · Cited by 3
Human Plasma Lipoprotein Metabolism
Pownall, H. J., & Gotto, A. M. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50005-6 · Cited by 3
ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in Egypt
Youssef, M. M., Elshaer, A., Elbaz, R., Ellazek, Y. A., El-Waseef, A., & Settin, A. (2018) · American Journal of Biochemistry and Molecular Biology · doi:10.3923/ajbmb.2018.16.22 · Cited by 3
[12] Immunochemical methods for quantification of human apolipoprotein C-III
Kashyap, M. L. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63014-6 · Cited by 3
Hermier, D., Sellier, N. N., Rousselot-Pailley, D., & Forgez, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.586_b.x · Cited by 3
Rodia, C. N., Li, D., Tambini, N. S., Johnson, Z. K., Jellison, E. R., Vella, A. T., & Kohan, A. B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/823690 · Cited by 4
Genetic Influences on Blood Lipids and Cardiovascular Disease Risk
Pollin, T. I., Ordovás, J. M., & Guevara‐Cruz, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00026-6 · Cited by 3
Molecular Basis of Hyperlipidemias: Lessons from the Finnish Gene Inheritage
KONTULA, K. K. (1990) · Annals of Medicine · doi:10.3109/07853899009147911 · Cited by 2
Clinical Aspects of Nonalcoholic Fatty Liver Disease
Mashav, N., & Shibolet, O. (2014) · Oxidative stress and disease · doi:10.1201/b17315-3 · Cited by 3
Gaudet, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00035-2 · Cited by 2
Hypolipidemic Effect of Peroxisome Proliferators
Hertz, R., Bishara-Shieban, J., & Bar‐Tana, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18683.x · Cited by 2
The role of apolipoproteins in lipid metabolism and atherogenesis: aspects in man and mice
Kreuzer, J., & von Hodenberg, E. (1996) · Springer eBooks · doi:10.1007/978-94-009-0083-7_18 · Cited by 2
Beheshti, I., Hanson, N. Q., Copeland, K. R., Garg, U. C., & Tsai, M. Y. (1995) · Clinical Biochemistry · doi:10.1016/0009-9120(94)00083-8 · Cited by 2
Endogenous and exogenous factors affecting lipoprotein lipase activity
Larsson, M. (2014) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Apolipoprotein A5: A newly identified gene impacting plasmatriglyceride levels in humans and mice
Pennacchio, L. A., & Rubin, E. M. (2002) · University of North Texas Digital Library (University of North Texas) · Cited by 2
ATVB In Focus: Lipoproteins, Inflammation, and Atherosclerosis
Scott, J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067043.83862.57 · Cited by 2
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00125-0 · Cited by 2
Maternal inheritance of severe hypertriglyceridemia impairs glucose metabolism in offspring
Ma, Y., Caiguo, Y., Kayoumu, A., Xin, G., Zhili, J., & George, L. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140139 · Cited by 1
Synergic effects of the ApoC3 and ApoA4 polymorphisms on the risk of hypertension
Kang, S. H., Kim, Y. R., & Hong, S.-H. (2017) · Genes & Genomics · doi:10.1007/s13258-017-0606-8 · Cited by 1
Atherosclerosis is the outcome of adaptive complexity in the Arterial Endothelial Microenvironment
Roy, T., Ray, A. G., & Bandyopadhyay, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00081-5 · Cited by 1
Effect of Genetic Variation on the Postprandial Response
Talmud, P. J., Waterworth, D. M., & Humphries, S. E. (2001) · KARGER eBooks · doi:10.1159/000059792 · Cited by 1
GPIHBP1: a new chylomicronemia gene
Beigneux, A. P., Gin, P., Davies, B. S. J., Yin, L., Weinstein, M. M., Bensadoun, A., Fong, L. G., & Young, S. G. (2008) · Future Lipidology · doi:10.2217/17460875.3.2.203 · Cited by 1
Nature vs nurture: genetic susceptibility and weight loss in hepatic steatosis
Huang, K. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01519_3.x · Cited by 1
An update on the cellular basis of atherosclerosis in hypertriglyceridemia
Ramprasad, M. P. (1995) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02873660 · Cited by 1
Sheetz, M. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41097-1 · Cited by 1
Eichenbaum‐Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B. C., Seed, M., Betteridge, D. J., Galton, D. J., Rubin, E. M., et al. (2002) · University of North Texas Digital Library (University of North Texas) · Cited by 1
Functional analysis of hepatic FOXO3 signalling in glucose and lipid metabolism
Gul, S. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3289 · Cited by 2
Genetic Influences on Blood Lipids and Cardiovascular Disease Risk
Ordovás, J. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50013-1 · Cited by 2
Regulation of Intestinal Apolipoprotein Gene Expression
Black, D. D. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1195-3_14 · Cited by 1
Common Mutations Underlying the Hypertriglyceridaemia/Low HDL Syndrome
Galton, D. J. (1993) · Springer eBooks · doi:10.1007/978-3-642-84949-7_13
Serum proteins in type 1 diabetes
Shalaly, N. D. (2007) · Figshare
Molecular Genetics of Plasma Lipid Transfer Proteins
Tall, A. R. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2860-9_16
Lackner, K. J., & Schmitz, G. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_17
Statin therapy in diabetic dyslipidemia : efficacy and mechanisms
Berk-Planken, I. I. L. (2003) · RePub (Erasmus University Rotterdam)
Les gènes d'apolipoprotéines Régulation de leur expression
Ribeiro, A., Lacorte, J. M., Cardot, P., & Chambaz, J. (2000) · Annales de l Institut Pasteur / Actualités · doi:10.1016/s0924-4204(00)80015-3
Zannis, V. I., Laccotripe, M., Makrides, S. C., Kardassis, D., & Zanni, E. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0355-8_7 · Cited by 1
Metadata
- Authors
- Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Science
- Published
- 1990-08-17
- Volume
- 249
- Issue
- 4970
- Pages
- 790-793
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1963872182
- Semantic Scholar
- be3dbcf0ed6239b54ab96520181db05f1ba0399f
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 7
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, HL-36461, HL-33435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, apolipoprotein C-III, transgenic mice, gene overexpression, primary hypertriglyceridemia, secondary hypertriglyceridemia, triglyceride metabolism, gene dosage
- MeSH terms
- Animals, Apolipoproteins C, Chylomicrons, Cloning, Molecular, DNA Restriction Enzymes, DNA, Recombinant, Humans, Lipoproteins, VLDL, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nucleic Acid Hybridization, RNA, Messenger, Triglycerides, Hypertriglyceridemia, Gene Expression, Mice, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.